Partial Knee Arthroplasty Market Overview
The Partial Knee Arthroplasty Market was valued at USD 2.0 billion in 2024 and is expected to grow from USD 2.1 billion in 2025 to USD 3.5 billion by 2035, registering a CAGR of 5.4% during the 2025–2035 forecast period. Increasing prevalence of osteoarthritis and other knee disorders, an aging population, rising obesity rates, growing healthcare expenditure, and increasing demand for minimally invasive orthopedic procedures are supporting market development.
Partial knee arthroplasty provides an option for patients with localized knee-joint damage by replacing only the affected compartment rather than the entire knee joint. The approach can preserve more healthy bone and tissue and is associated with a less extensive surgical procedure than total knee replacement in appropriate patients. Growing awareness of these potential benefits is contributing to demand for partial knee replacement technologies.
Technological advances are further reshaping the market. Robotic-assisted surgery, improved imaging, advanced implant designs, and patient-specific solutions are helping surgeons plan and perform procedures with greater precision. The increasing availability of minimally invasive techniques and custom-fit implants is also supporting the transition toward more personalized orthopedic care.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=591273
Smith & Nephew
Stryker
Orthofix
Exactech
Aesculap
Medtronic
Arthrosurface
B. Braun
MicroPort
Knee Innovations
Zimmer Biomet
Wright Medical Group
Tornier
DePuy Synthes
Conformis
The competitive landscape is characterized by continued investment in implant technology, surgical techniques, robotic assistance, and patient-specific solutions. Manufacturers are seeking to differentiate their offerings through improved implant designs, advanced materials, surgical tools, and technologies intended to support recovery and functional outcomes.
The market is also seeing strategic activity aimed at expanding product portfolios and strengthening capabilities. Stryker announced the acquisition of Arthrosurface in March 2025 to strengthen its partial knee resurfacing portfolio and support development of next-generation implants. Zimmer Biomet announced a strategic partnership with Conformis in June 2024 to co-develop patient-specific partial knee implants, combining customization technology with distribution capabilities. Exactech launched its KneeFlex cementless partial knee system in January 2025, designed around bone preservation and recovery considerations.
Rising incidence of osteoarthritis is one of the central drivers of the market. Knee disorders become increasingly common with age, and the growing elderly population is contributing to a larger pool of patients requiring orthopedic intervention. Partial knee arthroplasty can provide a treatment option for appropriately selected patients with disease limited to specific compartments of the knee.
Increasing obesity rates are another important factor. Excess body weight can place additional stress on the knee joint and is associated with increased risk of osteoarthritis. As the prevalence of obesity increases in many regions, demand for orthopedic procedures and joint-replacement technologies is also expected to expand.
Minimally invasive surgery is gaining importance across orthopedic care. Patients and healthcare providers are increasingly interested in procedures that can reduce tissue disruption, hospital stays, and recovery requirements. Partial knee replacement aligns with this broader shift when clinically appropriate, supporting demand for implants and surgical systems designed for less invasive procedures.
By product type, the market includes unicompartmental knee replacement, bicompartmental knee replacement, and patellofemoral knee replacement. Unicompartmental knee replacement held the largest segment valuation at USD 900 million in 2024 and is projected to reach USD 1.5 billion by 2035. Its adoption is supported by demand for less invasive treatment options and the ability to address disease limited to a single knee compartment.
Bicompartmental knee replacement addresses conditions affecting two compartments and is also experiencing steady development. The segment was valued at approximately USD 700 million in 2024. Patellofemoral knee replacement represented approximately USD 500 million in 2024 and provides a specialized option for patients with isolated patellofemoral arthritis.
Material selection is another important component of implant development. The market includes metal, plastic, ceramic, and alloy materials. Metal components are widely used because of their strength and durability. Plastic components can provide smooth articulating surfaces, while ceramic materials are valued for biocompatibility and wear characteristics. Alloy materials can combine properties of multiple metals to provide specific performance characteristics.
The surgical approach segment includes minimally invasive surgery and traditional surgery. Minimally invasive procedures are gaining traction because of their potential to reduce recovery time and postoperative discomfort. Traditional surgery remains an established approach, but advances in surgical technology and physician training are expanding the use of less invasive techniques.
Hospitals remain an important end-user category because they provide comprehensive orthopedic services and postoperative care. Ambulatory surgical centers are increasingly relevant as outpatient orthopedic procedures expand. These facilities can provide efficient surgical care for appropriately selected patients, while orthopedic clinics offer specialized services focused on musculoskeletal conditions and joint disorders.
Robotic-assisted surgery is becoming increasingly important to the competitive landscape. Advanced robotic systems can support surgical planning, implant positioning, and intraoperative guidance. Combined with improved imaging and digital planning technologies, these systems can help surgeons pursue precise implant placement and personalized surgical strategies.
Patient-specific implants represent another emerging opportunity. Custom-fit solutions can be designed around individual patient anatomy and may support more personalized treatment planning. The growing emphasis on personalized medicine across healthcare is therefore influencing the development of partial knee arthroplasty technologies.
North America held the largest regional market valuation in 2024 at USD 900 million and is projected to reach USD 1.5 billion by 2035. Advanced healthcare infrastructure, a growing elderly population, adoption of advanced surgical technologies, and increasing demand for orthopedic procedures support the regional market.
Europe is expected to maintain significant market activity, supported by established healthcare infrastructure, reimbursement policies, healthcare investment, and adoption of minimally invasive orthopedic procedures. The European market is projected to reach USD 1.2 billion by 2035.
Asia Pacific is experiencing notable growth as healthcare expenditure increases, orthopedic care becomes more accessible, and awareness of minimally invasive surgical procedures expands. A growing elderly population and investments in healthcare technology are creating additional opportunities for partial knee arthroplasty manufacturers.
South America and the Middle East and Africa currently represent smaller portions of the global market but offer opportunities for gradual expansion. Improvements in healthcare infrastructure, increasing investment in medical technology, and expanding access to orthopedic procedures can support future adoption.
Recent Developments and Market Trends:
- Rising prevalence of osteoarthritis is increasing demand for partial knee replacement procedures.
- An aging global population is expanding the pool of patients requiring orthopedic treatment.
- Growing obesity rates are contributing to the prevalence of knee disorders.
- Robotic-assisted surgical systems are improving precision and supporting advanced procedure planning.
- Minimally invasive approaches are gaining adoption because of their potential recovery benefits.
- Patient-specific and custom-fit implants are gaining traction in personalized orthopedic care.
- Improved implant materials and designs are supporting durability and functional performance.
- Ambulatory surgical centers are creating opportunities for outpatient partial knee procedures.
- Strategic partnerships and acquisitions are expanding product portfolios and technology capabilities.
- Asia Pacific is developing as an important growth region as orthopedic healthcare access improves.
Reasons to Buy the Report:
- Understand the projected development of the Partial Knee Arthroplasty Market through 2035.
- Review market size estimates for 2024, 2025, and 2035.
- Analyze the expected 5.4% CAGR during the 2025–2035 forecast period.
- Examine product types including unicompartmental, bicompartmental, and patellofemoral knee replacement.
- Evaluate materials including metal, plastic, ceramic, and alloy.
- Assess minimally invasive and traditional surgical approaches.
- Analyze demand across hospitals, ambulatory surgical centers, and orthopedic clinics.
- Understand regional market dynamics across North America, Europe, Asia Pacific, South America, and the Middle East and Africa.
- Identify key companies, technology developments, growth drivers, opportunities, and market trends.
Partial Knee Arthroplasty Market Segmentation
The Partial Knee Arthroplasty Market is segmented by Product Type, Material, Surgical Approach, End User, and Region. By product type, the market includes Unicompartmental Knee Replacement, Bicompartmental Knee Replacement, and Patellofemoral Knee Replacement. Unicompartmental knee replacement held the largest segment valuation in 2024 at USD 900 million and is projected to reach USD 1.5 billion by 2035.
By material, the market covers Metal, Plastic, Ceramic, and Alloy. Metal materials are supported by strength and durability, while plastic, ceramic, and alloy materials provide different characteristics related to articulation, biocompatibility, wear resistance, and implant performance.
By surgical approach, the market is divided into Minimally Invasive Surgery and Traditional Surgery. Minimally invasive surgery is gaining popularity as healthcare providers seek techniques that can reduce recovery requirements and improve patient experience.
By end user, the market includes Hospitals, Ambulatory Surgical Centers, and Orthopedic Clinics. Hospitals remain an important setting because of their comprehensive surgical and postoperative capabilities, while ambulatory centers and orthopedic clinics are benefiting from the expansion of outpatient and specialized orthopedic care.
By region, the market covers North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America represented the largest regional market in 2024 at USD 900 million and is projected to reach USD 1.5 billion by 2035. Europe is projected to reach USD 1.2 billion, while Asia Pacific is expected to experience notable expansion during the forecast period.
Future Outlook
The Partial Knee Arthroplasty Market is projected to increase from USD 2.1 billion in 2025 to USD 3.5 billion by 2035 at a CAGR of 5.4%. Future growth is expected to be supported by the aging population, increasing prevalence of osteoarthritis, rising obesity rates, growing healthcare expenditure, and demand for minimally invasive orthopedic procedures. Robotic-assisted surgery, advanced imaging, improved implant materials, and patient-specific technologies are expected to remain important areas of innovation. The expansion of ambulatory surgical care can create additional opportunities as appropriately selected procedures move toward outpatient settings. North America is expected to remain a significant regional market, while Europe and Asia Pacific will continue to contribute to global expansion through healthcare investment, technological adoption, and growing awareness of advanced orthopedic procedures. Strategic partnerships, acquisitions, and continued research into personalized implant solutions are expected to shape the competitive landscape through 2035.
